Author Archives: James Carroll

About James Carroll

Founder and CEO at THOR Photomedicine Ltd. About THOR

What makes THOR probes special (why we test LEDs)

Posted in Special Feature, Video of the Week | on What makes THOR probes special (why we test LEDs)

LLLT Literature Watch for January 2010

Some very interesting papers in this edition including a large back pain RCT of 546 patients, LLLT for major depression and anxiety from Harvard Medical School, Allergic Rhinitis  and another from Harvard on mechanism and dose.

Acute Low Back Pain with Radiculopathy: A Double-Blind, Randomized, Placebo-Controlled Study.

Konstantinovic LM, Kanjuh ZM, Milovanovic AN, Cutovic MR, Djurovic AG, Savic VG, Dragin AS, Milovanovic ND

1 Clinic for Rehabilitation, Medical School , Belgrade, Serbia.

Abstract Objective: The aim of this study was to investigate the clinical effects of low-level laser therapy (LLLT) in patients with acute low back pain (LBP) with radiculopathy. Background Data: Acute LBP with radiculopathy is associated with pain and disability and the important pathogenic role of inflammation. LLLT has shown significant anti-inflammatory effects in many studies. Materials and Methods: A randomized, double-blind, placebo-controlled trial was performed on 546 patients. Group A (182 patients) was treated with nimesulide 200 mg/day and additionally with active LLLT; group B (182 patients) was treated only with nimesulide; and group … Continue reading

Posted in Research | 2 Comments

Low-level laser irradiation promotes the recovery of atrophied gastrocnemius skeletal muscle in rats

Somehow this paper slipped through the net and missed my literature watch last year

Low-level laser irradiation promotes the recovery of atrophied gastrocnemius skeletal muscle in rats.

Nakano J, Kataoka, H, Sakamoto J, Origuchi T, Okita M, Yoshimura T

Unit of Physical Therapy and Occupational Therapy Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8052, Japan.

Low-level laser (LLL) irradiation promotes proliferation of muscle satellite cells, angiogenesis and expression of growth factors. Satellite cells, angiogenesis and growth factors play important roles in the regeneration of muscle. The objective of this study was to examine the effect of LLL irradiation on rat gastrocnemius muscle recovering from disuse muscle atrophy. Eight-week-old rats were subjected to hindlimb suspension for 2 weeks, after which they were released and recovered. During the recovery period, rats underwent daily LLL irradiation (Ga-Al-As laser; 830 nm; 60 mW; total, 180 s) to the right gastrocnemius muscle through the skin. The untreated left gastrocnemius muscle served as the control. In conjunction with LLL irradiation, 5-bromo-2-deoxyuridine (BrdU) was injected subcutaneously to label the nuclei of proliferating cells. After 2 … Continue reading

Posted in Research | on Low-level laser irradiation promotes the recovery of atrophied gastrocnemius skeletal muscle in rats

Roundup of the decade – a big thank you note

Wow, what a decade it has been for LLLT. Credibility is critical for acceptance by reimbursement and regulatory authorities as well as doctors and therapists. In the last ten years over 1,000 papers have been published that build on the work of the early pioneers. Highlights of this decade include: FDA clearance, publication in high impact factor journals such as Nature, Pain, PNAS, Spine, Muscle and Nerve, Stroke, Blood and, of course, The Lancet. Output from world renowned institutions including Harvard Medical School, NASA and the US Navy add further reassurance.

Posted in Special Feature | 2 Comments

The next decade of LLLT – the barriers to mainstream adoption

Because LLLT modulates cellular oxidation and energy production it could potentially affect  a wide range of diseases, injuries or other dysfunctions in the body.

By the end of the next decade, it is possible  LLLT may be used in almost every department of every hospital (and every medicine cabinet of every home).

Given the amount of good quality research published over the last decade, why isn’t it part of mainstream medicine already?

Posted in PBM/LLLT, Special Feature, THE FUTURE OF PBM/LLLT | on The next decade of LLLT – the barriers to mainstream adoption

62 new papers in the November 2009 LLLT literature watch

62 LLLT abstracts for you this month and of course we have to start with the Lancet paper on laser for neck pain. You can see a TV interview with the primary author Roberta Chow on the front page of our web site and an audio interview I did back in September is here.  There are as usual more papers showing how important dose and dose-rate-effects are. If you are unsure what W/cm2 are and how many you need then then it’s time you came on our “3 x 3 knowledge matrix” training course. There are trials on myofascial pain,lymphedema, plantar fasciitis, oral mucositis, psoriasis and more. read on

Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials.

Chow RT, Johnson MI, Lopes-Martins RA, Bjordal JM

Nerve Research Foundation, Brain and Mind Research Institute, University of Sydney, Sydney, NSW, Australia.

BACKGROUND: Neck pain is a common and costly condition for which pharmacological management … Continue reading

Posted in Research | 2 Comments

The Lancet systematic review and meta-analysis of LLLT for Neck Pain

This landmark study establishes that there is now more evidence for the use of laser for neck pain than any other medical procedure. For comment and to hear an interview with the lead author click here: The Lancet publishes that laser therapy helps neck pain

Posted in Industry | 1 Comment